Table 1

Characteristics of patients in both stages of the Phase I trial of Antagonist G

CharacteristicStage 1 (3 weekly) n = 15Stage 2 (weekly) n = 9
Gender
 Male125
 Female34
Age59 (36–65)a54 (34–75)a
WHO Performance Status1 (0–2)a1 (1–2)a
Cancer
 Renal40
 Colon22
 Non-small cell lung22
 Small cell lung03
 Mesothelioma20
 Other52
Previous chemotherapy98
Previous radiotherapy54
Previous immunotherapy10
No. of treatments Antagonist G2 (1–6)a6 (3–12)a
  • a Median (range).